GlassScriptPhysician profile
Edward Yost
NPI 1801976824
$1,684.35
in general payments reported to CMS, 2019-2025
18 companies · $203 in 2025
The $203 reported for 2025 was more than what 81% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $49.50 · 2021: $176 · 2022: $420 · 2023: $463 · 2024: $251 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $543.66 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $196.81 | 2019-2022 | |
| Azurity Pharmaceuticals, INC. | $153.92 | 2023-2025 | Horizant, Horizant |
| Valinor Pharma, LLC | $153.48 | 2024-2025 | Movantik |
| Boston Scientific Corporation | $150.00 | 2022 | |
| Abbott Laboratories | $140.03 | 2023 | Proclaim |
| Redhill Biopharma INC. | $70.97 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $68.17 | 2024-2025 | Belbuca, Xtampza |
| Indivior INC. | $43.05 | 2022-2023 | Sublocade |
| Vertex Pharmaceuticals Incorporated | $28.01 | 2025 | |
| Arbor Pharmaceuticals, INC. | $22.04 | 2022 | |
| Virtus Pharmaceuticals LLC | $21.31 | 2021 | |
| Daiichi Sankyo INC. | $20.68 | 2019 | |
| Orexo US, INC. | $18.78 | 2020 | |
| Bioventus LLC | $15.47 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.49 | 2021 | |
| Pacira Therapeutics, INC. | $12.46 | 2019 | |
| Kaleo, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Yost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.